Tay Therapeutics Ltd announces licencing of its oral BET blocker TayB2 to VYNE Therapeutics Inc as a treatment...
Up To Date
Latest News
German Medigene AG has acquired global rights to the CD40L-CD28 costimulatory switch receptor that modulates...
The European Commission has proposed to set binding sustainable aviation fuels (SAF) targets for the aviation...
In 2022, the Swiss biotech industry "continued to demonstrate its resilience, adapting well to geopolitical...
Targeted radiopharmaceuticals maker 3B Pharmaceuticals snaps US$40m upfront in a global exclusive licensing...
Syngenta has announced to leverage Biotalys’ AGROBODY™ technology platform to expand its biocontrol pipeline.